Immucell (ICCC) Interest & Investment Income (2018 - 2026)
Immucell's (ICCC) quarterly Interest & Investment Income came in at $65343.0 in Q2 2026, up 35.81% on a YoY basis from $48113.0 in Q2 2025, and up 106.4% quarter-over-quarter from $31659.0 in Q4 2025.
Powered by 
Analysis
Immucell (ICCC) Interest & Investment Income (2018 - 2026) Analysis & Trends
Immucell (ICCC) has reported Interest & Investment Income for 6 consecutive years, with $65343.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest & Investment Income rose 35.81% year-over-year to $65343.0; the trailing twelve-month figure through Jun 2026 stood at $186583.0 (up 32.81% YoY), and the FY2025 full-year result was $158709.0, up 104.25% from the prior year.
- Interest & Investment Income climbed to $65343.0 in Q2 2026 per ICCC's latest filing, from $31659.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $65343.0 in Q2 2026 and bottomed at $9527.0 in Q1 2024.
- Historically, Interest & Investment Income has averaged $32471.9 across 4 years, with a median of $36226.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Interest & Investment Income sank 76.55% in 2024, then soared 293.29% in 2025.
- Over 4 years, Interest & Investment Income stood at $14806.0 in 2023, then soared by 144.67% to $36226.0 in 2024, then dropped by 12.61% to $31659.0 in 2025, then soared by 106.4% to $65343.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $65343.0, $31659.0, and $41468.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 606,000.00 |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | - |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -10.18 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 65,343.00 |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 65,343.00 |
| Dec 31, 2025 | 31,659.00 |
| Sep 30, 2025 | 41,468.00 |
| Jun 30, 2025 | 48,113.00 |
| Mar 31, 2025 | 37,469.00 |
| Dec 31, 2024 | 36,226.00 |
| Sep 30, 2024 | 18,685.00 |
| Jun 30, 2024 | 13,264.00 |
| Mar 31, 2024 | 9,527.00 |
| Jun 30, 2023 | 14,806.00 |
| Mar 31, 2023 | 40,631.00 |
| Dec 31, 2019 | 27,150.00 |
| Sep 30, 2019 | 41,719.00 |
| Jun 30, 2019 | 47,099.00 |
| Mar 31, 2019 | 2,315.00 |
| Dec 31, 2018 | 4,031.00 |
| Sep 30, 2018 | 3,237.00 |
| Jun 30, 2018 | 3,209.00 |
| Mar 31, 2018 | 3,824.00 |